GlassScriptPhysician profile
Michael Lewis Ingram
NPI 1679527949
$2,314.20
in general payments reported to CMS, 2019-2025
17 companies · $273 in 2025
The $273 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $135 · 2021: $541 · 2022: $435 · 2023: $392 · 2024: $298 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $963.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $567.93 | 2019-2023 | Somatom Go.Top, Varian Treatment |
| Novocure INC. | $555.98 | 2019-2025 | Optune, Optune Gio |
| Regeneron Healthcare Solutions, INC. | $337.55 | 2019-2025 | Libtayo |
| Novartis Pharmaceuticals Corporation | $329.42 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $169.40 | 2023-2025 | Orgovyx |
| Myriad Genetic Laboratories, INC. | $59.30 | 2024 | Bracanalysis Cdx |
| Janssen Pharmaceuticals, INC | $42.43 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.27 | 2019-2022 | |
| Tactile Systems Technology INC | $31.07 | 2022-2023 | Flexitouch Plus, Entre Plus |
| Procept Biorobotics Corporation | $29.38 | 2024 | Aquabeam System |
| Boston Scientific Corporation | $28.26 | 2019 | |
| Elekta, INC. | $27.24 | 2021 | |
| Eisai INC. | $25.42 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $22.42 | 2023 | Imfinzi |
| Blue Earth Diagnostics | $16.61 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $16.58 | 2022 | |
| Progenics Pharmaceuticals, INC. | $13.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ingram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.